Respiratory burst inhibition in human neutrophils by ultra‐low doses of [D‐Ala2]methionine enkephalinamide
- 7 October 1991
- journal article
- Published by Wiley in FEBS Letters
- Vol. 291 (1) , 84-86
- https://doi.org/10.1016/0014-5793(91)81109-l
Abstract
An ultra-low dose (10−14 M) of opioid peptide [D-Ala2]methionine enkephalinamide (DAMEA) is found to exert an inhibitory effect on the production of reactive oxygen species (respiratory burst) in human neutrophils. The validity of this phenomenon has been verified in a series of studies that comprised 30 experiments. The inhibition has proved to be statistically significant (P<0.001). The dose-response dependence of the effect (10−15−10−9 M) followed a characteristic biphasic pattern (with the maximum effect at ultra-low doses). An opioid antagonist, naloxone partially blocks the inhibitory effect, which indicates that the DAMEA action is at least partially mediated by opioid receptorsKeywords
This publication has 5 references indexed in Scilit:
- The role of adhesive interactions and extracellular matrix fibronectin from human polymorphonuclear leukocytes in the respiratory burstBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1991
- Immunoregulatory effects of α-endorphin, β-endorphin, methionine-enkephalin, and adrenocorticotropic hormone on anti-tetanus toxoid antibody synthesis by human lymphocytesClinical Immunology and Immunopathology, 1989
- Role of opioid neuropeptides in immunoregulationProgress in Neurobiology, 1989
- Electronic, Steric, and Hydrophobic Factors Influencing the Action of Enkephalin-Like Peptides on Opiate ReceptorsHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1981
- The Glomerular Permeability Determined by Dextran Clearance Using Sephadex Gel FiltrationScandinavian Journal of Clinical and Laboratory Investigation, 1968